WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003075947) USE OF EGFR TRANSACTIVATION INHIBITORS IN HUMAN CANCER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/075947    International Application No.:    PCT/EP2003/002361
Publication Date: 18.09.2003 International Filing Date: 07.03.2003
IPC:
A61K 38/16 (2006.01), A61K 38/18 (2006.01), A61K 38/48 (2006.01), A61K 38/55 (2006.01)
Applicants: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. [DE/DE]; Hofgartenstrasse 8 80539 München (DE) (For All Designated States Except US).
ULLRICH, Axel [DE/DE]; (DE) (For US Only).
SCHÄFER, Beatrix [DE/DE]; (DE) (For US Only).
FISCHER, Oliver [DE/DE]; (DE) (For US Only).
GSCHWIND, Andreas [DE/DE]; (DE) (For US Only).
LESERER, Michael [DE/DE]; (DE) (For US Only)
Inventors: ULLRICH, Axel; (DE).
SCHÄFER, Beatrix; (DE).
FISCHER, Oliver; (DE).
GSCHWIND, Andreas; (DE).
LESERER, Michael; (DE)
Agent: WEICKMANN & WEICKMANN; Postfach 860 820 81635 München (DE)
Priority Data:
02005452.4 08.03.2002 EP
Title (EN) USE OF EGFR TRANSACTIVATION INHIBITORS IN HUMAN CANCER
(FR) UTILISATION D'INHIBITEURS DE LA TRANSACTIVATION DE L'EGFR DANS LE TRAITEMENT DU CANCER HUMAIN
Abstract: front page image
(EN)The present invention relates to the use of a compound which is capable of inhibiting activation of a growth factor receptor of the EGFR-family for the prevention or treatment of processes associated with increased G-protein mediated signal transduction.
(FR)L'invention porte sur l'utilisation d'un composé capable d'inhiber l'activation d'un récepteur du facteur de croissance de la famille des EGFR pour la prévention ou le traitement de processus associés à un accroissement de la transduction de signaux médié par la protéine G.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)